Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Daniel M. Hartung, PharmD
JCP
Letter to the Editor
Reply to Overestimating the Prevalence of Subtherapeutic Dosing of Atypical Antipsychotics
August 15, 2009
Daniel M. Hartung
,
Jennifer P. Wisdom
,
David A. Pollack
, et al
JCP
Original Research
Patterns of Atypical Antipsychotic Subtherapeutic Dosing Among Oregon Medicaid Patients
October 31, 2008
Daniel M. Hartung
,
Jennifer P. Wisdom
,
David A. Pollack
, et al
